Operating Lease, Liability of Intellia Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Intellia Therapeutics, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
Intellia Therapeutics, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2025 was $93,329,000, a 56% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Intellia Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$93,329,000	-$116,869,000	-56%	31 Dec 2025	10-K	26 Feb 2026	2025	FY
Q3 2025	$97,966,000			30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$102,591,000			30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$119,253,000			31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$210,198,000	+$94,852,000	+82%	31 Dec 2024	10-K	27 Feb 2025	2024	FY
Q4 2023	$115,346,000	-$15,357,000	-12%	31 Dec 2023	10-K	22 Feb 2024	2023	FY
Q4 2022	$130,703,000	+$56,680,000	+77%	31 Dec 2022	10-K	23 Feb 2023	2022	FY
Q4 2021	$74,023,000	+$34,718,000	+88%	31 Dec 2021	10-K	24 Feb 2022	2021	FY
Q4 2020	$39,305,000	+$20,930,000	+114%	31 Dec 2020	10-K	26 Feb 2021	2020	FY
Q4 2019	$18,375,000			31 Dec 2019	10-K	27 Feb 2020	2019	FY
Q3 2019	$19,647,000			30 Sep 2019	10-Q	31 Oct 2019	2019	Q3
Q2 2019	$19,669,000			30 Jun 2019	10-Q	01 Aug 2019	2019	Q2
Q1 2019	$19,513,000			31 Mar 2019	10-Q	02 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.